| In vitro models for the prediction of in vivo performance of oral dosage forms ES Kostewicz, B Abrahamsson, M Brewster, J Brouwers, J Butler, ... European Journal of Pharmaceutical Sciences 57, 342-366, 2014 | 407 | 2014 |
| Use of pharmaceutical salts and cocrystals to address the issue of poor solubility DP Elder, R Holm, HL De Diego International journal of pharmaceutics 453 (1), 88-100, 2013 | 399 | 2013 |
| Liposomes: Advancements and innovation in the manufacturing process S Shah, V Dhawan, R Holm, MS Nagarsenker, Y Perrie Advanced Drug Delivery Reviews 154, 102-122, 2020 | 383 | 2020 |
| Lipid-based formulations for oral administration of poorly water-soluble drugs H Mu, R Holm, A Müllertz International journal of pharmaceutics 453 (1), 215-224, 2013 | 346 | 2013 |
| In vivo methods for drug absorption–comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient … E Sjögren, B Abrahamsson, P Augustijns, D Becker, MB Bolger, ... European Journal of Pharmaceutical Sciences 57, 99-151, 2014 | 299 | 2014 |
| Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs CAS Bergström, R Holm, SA Jørgensen, SBE Andersson, P Artursson, ... European Journal of Pharmaceutical Sciences 57, 173-199, 2014 | 284 | 2014 |
| In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS) N Thomas, R Holm, A Müllertz, T Rades Journal of controlled release 160 (1), 25-32, 2012 | 231 | 2012 |
| Bile salts and their importance for drug absorption R Holm, A Müllertz, H Mu International Journal of Pharmaceutics 453 (1), 44-55, 2013 | 219 | 2013 |
| Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems … R Holm, CJH Porter, GA Edwards, A Müllertz, HG Kristensen, ... European journal of pharmaceutical sciences 20 (1), 91-97, 2003 | 213 | 2003 |
| Pharmaceutical excipients—quality, regulatory and biopharmaceutical considerations DP Elder, M Kuentz, R Holm European journal of pharmaceutical sciences 87, 88-99, 2016 | 161 | 2016 |
| Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs N Thomas, R Holm, M Garmer, JJ Karlsson, A Müllertz, T Rades The AAPS journal 15, 219-227, 2013 | 154 | 2013 |
| Comparative study of different methods for the prediction of drug–polymer solubility MM Knopp, L Tajber, Y Tian, NE Olesen, DS Jones, A Kozyra, K Lobmann, ... Molecular pharmaceutics 12 (9), 3408-3419, 2015 | 150 | 2015 |
| Oral biopharmaceutics tools–time for a new initiative–an introduction to the IMI project OrBiTo H Lennernäs, L Aarons, P Augustijns, S Beato, M Bolger, K Box, ... European Journal of Pharmaceutical Sciences 57, 292-299, 2014 | 130 | 2014 |
| Influence of polymer molecular weight on drug–polymer solubility: a comparison between experimentally determined solubility in PVP and prediction derived from solubility in monomer MM Knopp, NE Olesen, P Holm, P Langguth, R Holm, T Rades Journal of pharmaceutical sciences 104 (9), 2905-2912, 2015 | 120 | 2015 |
| Lipid-based Formulations for Danazol Containing a Digestible Surfactant, Labrafil M2125CS: In Vivo Bioavailability and Dynamic In Vitro Lipolysis A Larsen, R Holm, ML Pedersen, A Müllertz Pharmaceutical research 25, 2769-2777, 2008 | 116 | 2008 |
| Solid lipid nanocarriers in drug delivery: characterization and design H Mu, R Holm Expert opinion on drug delivery 15 (8), 771-785, 2018 | 115 | 2018 |
| In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate N Thomas, K Richter, TB Pedersen, R Holm, A Müllertz, T Rades The AAPS journal 16, 539-549, 2014 | 112 | 2014 |
| Solid state compatibility studies with tablet excipients using non thermal methods K Liltorp, TG Larsen, B Willumsen, R Holm Journal of pharmaceutical and biomedical analysis 55 (3), 424-428, 2011 | 112 | 2011 |
| Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches–a PEARRL review F Ditzinger, DJ Price, AR Ilie, NJ Köhl, S Jankovic, G Tsakiridou, ... Journal of Pharmacy and Pharmacology 71 (4), 464-482, 2019 | 111 | 2019 |
| Food for thought: formulating away the food effect–a PEARRL review JP O'Shea, R Holm, CM O'Driscoll, BT Griffin Journal of Pharmacy and Pharmacology 71 (4), 510-535, 2019 | 106 | 2019 |
